3 results about "Panax japonicus" patented technology

This invention provides a traditional Chinese medicine compound for treating chronic pharyngitis, belonging to the field of biomedical technology. The invention comprises a self-formulated traditional Chinese medicine compound consisting of *Pearl Umbrella*, *Trichosanthes kirilowii*, *Sapindus mukorossi*, *Lycoperdon perlatum*, *Panax japonicus*, *Gnaphalium affine*, *Aster tataricus*, and prepared licorice root for the treatment of chronic pharyngitis. Addressing the complex pathogenesis of chronic pharyngitis, characterized by a mixture of deficiency and excess, phlegm and blood stasis, and yin deficiency, the ingredients in the compound are rationally combined and work synergistically to achieve the effects of promoting blood circulation without depleting yin, clearing heat without harming yang, resolving phlegm without hindering the spleen, nourishing yin without being cloying, combining tonification and purgation, using both warming and cooling methods, and treating both the root cause and the symptoms. This compound is suitable for the treatment and management of chronic pharyngitis.

The application belongs to the technical field of traditional Chinese medicine, and particularly relates to a preparation method and application of a Gastrodia elata Yin-boosting oral preparation. The oral preparation comprises the following raw materials in parts by weight: Gastrodia elata 20-25 parts, Rehmannia glutinosa 15-20 parts, Cornus officinalis 14-17 parts, Fructus Lycii 17-21 parts, Rubus corchorifolius 15-20 parts, Anoectochilus roxburghii 10-15 parts, Ophiopogon japonicus 10-20 parts, Polygonatum odoratum 10-14 parts, Panax ginseng 5-10 parts, Atractylodes macrocephala 7-12 parts, Poria cocos 5-10 parts, Ziziphus jujuba var. spinosa 10-15 parts, Schisandra chinensis 5-10 parts, Angelica dahurica 5-8 parts, Angelica sinensis 1-5 parts, and Glycyrrhiza uralensis 3-8 parts. Animal experiments prove that the oral preparation can prolong the exhaustive swimming time of mice, reduce the content of blood lactic acid and serum urea of mice after swimming, increase the storage of liver glycogen, and has a significant anti-fatigue effect.

This invention discloses the application of *Gynostemma pentaphyllum* polysaccharide in the preparation of drugs against porcine reproductive and respiratory syndrome virus (PRRSV). This invention explores the regulatory effect of *Gynostemma pentaphyllum* polysaccharide on PRRSV replication, and for the first time discovers that *Gynostemma pentaphyllum* polysaccharide can effectively inhibit PRRSV replication in Marc-145 cells. Based on this, this invention proposes a new application of *Gynostemma pentaphyllum* polysaccharide in the preparation of drugs against PRRSV, preferably with a concentration of 12.5 μg / mL to 100 μg / mL. This invention enriches the research on the antiviral activity of *Gynostemma pentaphyllum* polysaccharide and also provides a new technical means for the research and clinical application of anti-PRRSV drugs.